Who is sponsoring NCT05937711?

NCT05937711 is sponsored by Ilker Fatih Sari.

What condition does NCT05937711 study?

NCT05937711 studies Fibromyalgia.

Is NCT05937711 still recruiting?

NCT05937711 is currently completed. Last updated 10 July 2023.

Last reviewed 2023-07-10 · How we verify

NCT05937711

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Transcutaneous Posterior Tibial Nerve Stimulation in Patients With Fibromyalgia

Completed NA Last updated 10 July 2023

What this trial tests

NA trial testing Transcutaneous Posterior Tibial Nerve Stimulation + Duloxetine 30 MG in Fibromyalgia in 64 participants. Completed in 23 May 2022.

Timeline

2 November 2020

Primary endpoint
23 May 2022

23 May 2022

Quick facts

Lead sponsor	Ilker Fatih Sari
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	64
Start date	2 November 2020
Primary completion	23 May 2022
Estimated completion	23 May 2022
Sites	2 locations across Turkey (Türkiye)

Drugs / interventions tested

Transcutaneous Posterior Tibial Nerve Stimulation + Duloxetine 30 MG
Duloxetine 30 MG — full drug profile →

Conditions studied

Fibromyalgia — all drugs for Fibromyalgia →

Sponsor

Ilker Fatih Sari

Who can join

Adults 18 to 65, female only, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to investigate the effectiveness of posterior tibial nerve stimulation (PTNS) in reducing pain, improving quality of life, and decreasing disease severity in patients with fibromyalgia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Effect of Transcutaneous Posterior Tibial Nerve Stimulation on Pain and Quality of Life in Patients with Fibromyalgia: A Single-Blind, Randomized Controlled Trial.
Sarı İF, İlhanlı İ, Mızrak T, Kulaklı F, et al · · 2023 · PMID 37568391 · DOI 10.3390/jcm12154989

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
NCT07245303 — Neural Mechanisms of Light Driven Analgesia · NA · recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
NCT07465991 — The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05937711 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ilker Fatih Sari
Last refreshed: 10 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05937711.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing